SCHEMBL17620686

SCHEMBL17620686

CCOC(=O)c1cn2c3c(sc2n1)CCCCC3

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.52
KDM4E B2RXH2 7/20 0.52
GAA P10253 6/20 0.52
MAPT P10636 4/20 0.52
HPGD P15428 4/20 0.52
KMT2A Q03164 3/20 0.52
HSD17B10 Q99714 3/20 0.52
MAPK1 P28482 2/20 0.52
POLB P06746 2/20 0.52
MEN1 O00255 1/20 0.52
LMNA P02545 1/20 0.52
GLA P06280 1/20 0.52
HTT P42858 1/20 0.52
HDAC6 Q9UBN7 1/20 0.49
NPC1 O15118 4/20 0.46
RAB9A P51151 4/20 0.46
TP53 P04637 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
NFKB1 P19838 1/20 0.46
GFER P55789 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3601508 0.99 KDM4E (0.53) ALDH1A1KDM4EGAAMAPTHPGD
SCHEMBL2928930 0.96 KDM4E (0.50) ALDH1A1KDM4EGAAMAPTHPGD
SCHEMBL3588423 0.82 GAA (0.43) ALDH1A1KDM4EGAAMAPTHPGD
SCHEMBL17621022 0.81 GAA (0.42) ALDH1A1KDM4EGAAMAPTHPGD
SCHEMBL17620685 0.81 GAA (0.42) ALDH1A1KDM4EGAAMAPTHPGD
SCHEMBL17620682 0.81 ALDH1A1 (0.45) ALDH1A1KDM4EGAAMAPTHPGD
SCHEMBL17620969 0.80 ALDH1A1 (0.55) ALDH1A1KDM4EGAAMAPTHPGD
SCHEMBL17620687 0.79 GAA (0.42) ALDH1A1KDM4EGAAMAPTHPGD
SCHEMBL17620688 0.79 ALDH1A1 (0.42) ALDH1A1KDM4EGAAMAPTHPGD
SCHEMBL17620690 0.79 GAA (0.42) ALDH1A1KDM4EGAAMAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10385069-B2 Imidazo[2,1-B]thiazole and 5,6-dihydroimidazo[2,1-B]thiazole derivatives useful as S100-inhibitors ACTIVE BIOTECH AB (SE) 2019-08-20 US claimed
US-10385069-B2 Imidazo[2,1-B]thiazole and 5,6-dihydroimidazo[2,1-B]thiazole derivatives useful as S100-inhibitors ACTIVE BIOTECH AB (SE) 2019-08-20 US disclosed
US-10385069-B2 Imidazo[2,1-B]thiazole and 5,6-dihydroimidazo[2,1-B]thiazole derivatives useful as S100-inhibitors ACTIVE BIOTECH AB (SE) 2019-08-20 US disclosed
US-20180282348-A1 IMIDAZO[2,1-B]THIAZOLE AND 5,6-DIHYDROIMIDAZO[2,1-B]THIAZOLE DERIVATIVES USEFUL AS S100-INHIBITORS ACTIVE BIOTECH AB (SE) 2018-10-04 US disclosed
WO-2016042172-A1 IMIDAZO[2,1-B]THIAZOLE AND 5,6-DIHYDROIMIDAZO[2,1-B]THIAZOLE DERIVATIVES USEFUL AS S100-INHIBITORS ACTIVE BIOTECH AB (SE) 2016-03-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180282348-A1 IMIDAZO[2,1-B]THIAZOLE AND 5,6-DIHYDROIMIDAZO[2,1-B]THIAZOLE DERIVATIVES USEFUL AS S100-INHIBITORS S100B, S100P, S100A4 ALDH1A1 993/4885KDM4E 3946/4885GAA 3238/4885
US-10385069-B2 Imidazo[2,1-B]thiazole and 5,6-dihydroimidazo[2,1-B]thiazole derivatives useful as S100-inhibitors S100B, S100P, S100A4 ALDH1A1 993/4885KDM4E 3946/4885GAA 3238/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.